Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. méd. Chile ; 139(9): 1192-1195, set. 2011. ilus
Article in Spanish | LILACS | ID: lil-612244

ABSTRACT

Drepanocytic anemia is an uncommon hereditary disease in Chile. The heterozygous state of drepanocytic anemia or "sickle trait" has a frequency of 8 percent among Afro-Americans. A small number of patients carrying hemoglobin S are homozygous, with clinical manifestations of hemolytic anemia and thrombotic disease. Sickle trait is usually asymptomatic. We report a 59-year-old male who presented an acute abdominal pain and dyspnea while staying at high altitude. Six days later, an angio CAT scan showed the presence of a subcapsular splenic hematoma that was managed conservatively. Sickle cell induction with sodium metabisulphite was positive. Hemoglobin electrophoresis confirmed the sickle trait.


Subject(s)
Humans , Male , Middle Aged , Altitude , Altitude Sickness/etiology , Hematoma/etiology , Sickle Cell Trait/complications , Splenic Diseases/etiology , Abdominal Pain/etiology , White People
2.
Rev. méd. Chile ; 137(4): 552-558, abr. 2009. tab
Article in Spanish | LILACS | ID: lil-518591

ABSTRACT

The search for prognostic factors in multiple myeloma has identified the genetic profile of the tumor as the main determinant of patient survival and response to treatment. There is an association between a dismal prognosis and the presence of t(4:14) translocations or 17p deletion, determined by fluorescent in situ hybridization (FISH) or the detection of chromosome 13 deletion using conventional cytogenetic techniques. These alterations define a subpopulation that comprises 25% of patients with a bad prognosis even if they are treated with high dose chemotherapy. These patients should be early derived to more specific therapies. In the other hand, the other 75% of patients without a genetic risk factor, have a higher probability of success with conventional treatment.


Subject(s)
Humans , Multiple Myeloma/genetics , Gene Deletion , Genetic Markers/genetics , Multiple Myeloma/diagnosis , Prognosis , Translocation, Genetic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL